Bio-Rad Laboratories | BIO - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Agilent USD 2.27B 35M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Bio Techne USD 153.28M 12.85M 2026-03
Bio-Rad Laboratories USD 917M 400M 2026-03
Bruker USD 1.36B 75.9M 2026-03
Charles River Laboratories USD 1.09B 26.61M 2026-03
Danaher USD 7.46B 653M 2026-03
General Electric Aerospace USD 40.03B 1.05B 2026-03
Illumina USD 1.57B 19M 2026-03
IQVIA Holdings USD 8.33B 9M 2026-03
Laboratory Of America USD 2.64B 182.5M 2026-03
Merck USD 26.94B 1.38B 2026-03
Mettler Toledo International USD 1.11B 89.76M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
OraSure Technologies USD 44.08M 4.29M 2026-03
Pacific Biosciences Of California USD 65.36M 7.48M 2026-03
Quest Diagnostics USD 2.18B 101M 2026-03
Repligen USD 126.21M 9.62M 2026-03
Revvity USD 1.24B 92.6M 2026-03
Roche Holding CHF 28B 421M 2025-12
Siemens EUR 49.52B 168M 2026-03
Standard Biotools USD 42.2M 66.1M 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Tosoh JPY 354.52B 14.24B 2026-03
Waters USD 1.24B 11.8M 2025-12